{"transactions":[{"id":2826766,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":142111,"kind":"person","name":"DEMAREE JOHN","position":1,"cik":"0001744959","reported_name":"DEMAREE JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-01T20:10:55.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":43177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 25, 2021 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 25, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":43177,"derivative":{"exercise_price":14.56,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":43177},"source":{"system":"sec-edgar","filing":"0001209191-21-015483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1744959/000120919121015483/doc4.xml","form_type":"4"}},{"id":2826765,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":142111,"kind":"person","name":"DEMAREE JOHN","position":1,"cik":"0001744959","reported_name":"DEMAREE JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-03-01T20:10:55.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":15849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 25, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 15,849 newly awarded RSUs and 8,146 shares of common stock, which include 646 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020."}],"balance_after":23995,"source":{"system":"sec-edgar","filing":"0001209191-21-015483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744959/000120919121015483/doc4.xml","form_type":"4"}},{"id":3045637,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":142111,"kind":"person","name":"DEMAREE JOHN","position":1,"cik":"0001744959","reported_name":"DEMAREE JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-27T16:00:34.000Z","date":"2020-08-26","kind":"purchase","acquired":true,"shares":7500,"price":14.535,"value":109012.5,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001209191-20-048515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744959/000120919120048515/doc4.xml","form_type":"4"}},{"id":3205658,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":142111,"kind":"person","name":"DEMAREE JOHN","position":1,"cik":"0001744959","reported_name":"DEMAREE JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2020-03-17T17:30:53.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":151200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 16, 2020.  The shares underlying this option vest as to 25% of the shares on March 16, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":151200,"derivative":{"exercise_price":16.5,"expiration_date":"2030-03-15","underlying":"Common Stock","underlying_shares":151200},"source":{"system":"sec-edgar","filing":"0001209191-20-019703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744959/000120919120019703/doc4.xml","form_type":"4"}},{"id":3284701,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":142111,"kind":"person","name":"DEMAREE JOHN","position":1,"cik":"0001744959","reported_name":"DEMAREE JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-02-07T16:15:07.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% of the shares on February 06, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":21.08,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-20-001009","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744959/000156218020001009/primarydocument.xml","form_type":"4"}},{"id":3713505,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":142111,"kind":"person","name":"DEMAREE JOHN","position":1,"cik":"0001744959","reported_name":"DEMAREE JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-02T17:28:43.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% of the shares on January 02, 2020, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":19.56,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001562180-19-000088","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744959/000156218019000088/primarydocument.xml","form_type":"4"}},{"id":3735803,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":142111,"kind":"person","name":"DEMAREE JOHN","position":1,"cik":"0001744959","reported_name":"DEMAREE JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-12-11T16:08:17.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":1000,"price":33.1511,"value":33151.1,"ownership":{"direct":true},"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001562180-18-004904","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744959/000156218018004904/primarydocument.xml","form_type":"4"}},{"id":3871866,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":142111,"kind":"person","name":"DEMAREE JOHN","position":1,"cik":"0001744959","reported_name":"DEMAREE JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-06T16:47:07.000Z","date":"2018-07-03","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% of the shares on July 3, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":225000,"derivative":{"exercise_price":45.5,"expiration_date":"2028-07-03","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-18-041879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744959/000120919118041879/doc4.xml","form_type":"4"}}]}